Adverum Biotechnologies Inc Sustainability Reports

Adverum Biotechnologies is a clinical-stage gene therapy company focused on developing solutions for ocular and rare diseases. Its lead product candidate leverages intravitreal gene therapy to deliver long-term protection against vision loss.

Sector: Manufacturing

Country: United States

Exchange: Nasdaq

LEI: 529900ZEDOOZL1EWHJ89

FIGI: BBG006D9MR26

11 reports from 2014 to 2024

• Adverum Biotechnologies Inc 2024 Form 10-K
• Adverum Biotechnologies Inc 2023 Form 10-K
• Adverum Biotechnologies Inc 2022 Annual Report on Form 10-K
• Adverum Biotechnologies Inc 2021 Annual Report
• Adverum Biotechnologies Inc 2020 Form 10-K